Literature DB >> 3489036

Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen.

C L Atkin, B C Cole, G J Sullivan, L R Washburn, B B Wiley.   

Abstract

Previous studies established that Mycoplasma arthritidis produces a soluble T cell mitogen (MAM), and that response of murine T cells to MAM is genetically restricted. MAM appeared predominantly in the supernatants of senescent cultures, but was not extracted in significant amounts from whole cells. A quantitative assay of MAM activity was devised. MAM formed noncovalent complexes with nucleic acids and uncharacterized high m.w. constituents of sera and of complex media. Partially purified MAM was adsorbed or denatured by glass and plastic surfaces. MAM was protease-labile, had pI greater than or equal to 9, and had Mr ca 15,000 according to gel filtration experiments. MAM was a very minor component of culture supernatant proteins, and even after 200- to estimated 5 X 10(4)-fold purification was not identified as a stainable or ultraviolet-absorbing entity in electrophoretigrams or chromatograms. It was estimated that MAM was half-optimally active at less than 1000th the half-optimal concentration of concanavalin A or phytohemagglutinin. Culture supernatants and highly purified MAM exhibited the same haplotype specificity (H-2k-dependent response) for stimulated proliferation of lymphocytes and for induction of interferon in vitro.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3489036

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  25 in total

1.  Allelic polymorphisms at the H-2A and HLA-DQ loci influence the response of murine lymphocytes to the Mycoplasma arthritidis superantigen MAM.

Authors:  B C Cole; A D Sawitzke; E A Ahmed; C L Atkin; C S David
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

Review 2.  T lymphocyte-stimulating microbial toxins as "superantigens".

Authors:  B Fleischer
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

3.  Activation of a murine T-cell hybridoma by cationized bacteria.

Authors:  D N Shapiro; J Varani; I Ginsburg
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

4.  Mycoplasma arthritidis mitogen up-regulates human NK cell activity.

Authors:  J A D'Orazio; B C Cole; J Stein-Streilein
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

Review 5.  Role of protein glycosylation in immune regulation.

Authors:  E F Hounsell; M J Davies
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

6.  Mycoplasma arthritidis-derived superantigen induces proinflammatory monokine gene expression in the THP-1 human monocytic cell line.

Authors:  R al-Daccak; K Mehindate; J Hébert; L Rink; S Mecheri; W Mourad
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

7.  Replacement of the DR alpha chain with the E alpha chain enhances presentation of Mycoplasma arthritidis superantigen by the human class II DR molecule.

Authors:  T Sawada; R Pergolizzi; K Ito; J Silver; C Atkin; B C Cole; M D Chang
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product.

Authors:  P F Mühlradt; H Quentmeier; E Schmitt
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

9.  MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits.

Authors:  P F Mühlradt; U Schade
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

10.  Macrophage-activating factor extracted from mycoplasmas.

Authors:  M Takema; S Oka; K Uno; S Nakamura; H Arita; K Tawara; K Inaba; S Muramatsu
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.